When evaluating controversial therapies, what is an appropriate public engagement approach?

When evaluating controversial therapies, what is an appropriate public engagement approach?

• A. Do not involve stakeholders
• B. Provide clear, balanced information and disclose uncertainties
• C. Promote only positive outcomes
• D. Focus solely on cost savings

Answer: (B)

Transparency and balanced information are essential when engaging the public about controversial therapies. The best approach is to provide clear, balanced information and disclose uncertainties so people can weigh benefits, risks, and limitations, make informed choices, and participate in ongoing dialogue. This includes outlining the strength of the evidence, what is known and unknown, any potential conflicts of interest, and inviting questions from patients, families, clinicians, and the wider community. Other approaches fall short because they exclude stakeholders, push only positive outcomes, or focus on cost savings at the expense of patient welfare and ethical considerations.

Transparency and balanced information are essential when engaging the public about controversial therapies. The best approach is to provide clear, balanced information and disclose uncertainties so people can weigh benefits, risks, and limitations, make informed choices, and participate in ongoing dialogue. This includes outlining the strength of the evidence, what is known and unknown, any potential conflicts of interest, and inviting questions from patients, families, clinicians, and the wider community. Other approaches fall short because they exclude stakeholders, push only positive outcomes, or focus on cost savings at the expense of patient welfare and ethical considerations.